Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis
Open Access
- 25 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 36 (3), 239-260
- https://doi.org/10.1007/s10928-009-9120-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and NeckThe Journal of Clinical Pharmacology, 2008
- Population pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer developmentBritish Journal of Cancer, 2008
- Cell Surface Receptors for Signal Transduction and Ligand Transport: A Design Principles StudyPLoS Computational Biology, 2007
- Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic ProteinsClinical Pharmacokinetics, 2005
- Pharmacokinetic aspects of biotechnology productsJournal of Pharmaceutical Sciences, 2004
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal Of Cancer, 2001
- Proliferative Response of Fibroblasts Expressing Internalization‐Deficient Epidermal Growth Factor (EGF) Receptors Is Altered via Differential EGF Depletion EffectBiotechnology Progress, 1994
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980